Substance and Non-Substance Addiction. (Record no. 132199)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 11330nam a22005293i 4500 |
| 001 - CONTROL NUMBER | |
| control field | EBC5122222 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | MiAaPQ |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240729131547.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m o d | |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr cnu|||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 240724s2017 xx o ||||0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9789811055621 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 9789811055614 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (MiAaPQ)EBC5122222 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (Au-PeEL)EBL5122222 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (CaPaEBR)ebr11464080 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)1011234572 |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | MiAaPQ |
| Language of cataloging | eng |
| Description conventions | rda |
| -- | pn |
| Transcribing agency | MiAaPQ |
| Modifying agency | MiAaPQ |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RC321-580 |
| 082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 616.86059999999998 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Zhang, Xiaochu. |
| 245 10 - TITLE STATEMENT | |
| Title | Substance and Non-Substance Addiction. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 1st ed. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | Singapore : |
| Name of producer, publisher, distributor, manufacturer | Springer Singapore Pte. Limited, |
| Date of production, publication, distribution, manufacture, or copyright notice | 2017. |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | ©2017. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (357 pages) |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 490 1# - SERIES STATEMENT | |
| Series statement | Advances in Experimental Medicine and Biology Series ; |
| Volume/sequential designation | v.1010 |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Intro -- Foreword -- Contents -- Contributors -- Part I: Overview of Substance and Non-substance Addictions -- Chapter 1: Received View of Addiction, Relapse and Treatment -- 1.1 Understanding Addiction -- 1.1.1 Biological/Medicinal Perspective of Addiction -- 1.1.2 Psychological Perspective of Addiction -- 1.1.2.1 Addiction and Voluntary Action -- 1.1.2.2 Addiction, Compulsivity and Impulsivity -- 1.1.3 Social/Cultural Perspective of Addiction -- 1.2 Treating Addiction and Relapse: Biopsychosocial Perspective -- 1.2.1 Pharmacological Perspective -- 1.2.2 Psychological Perspective -- 1.2.3 Social Perspective -- 1.3 Conclusion -- References -- Chapter 2: Definition of Substance and Non-substance Addiction -- 2.1 Introduction -- 2.2 Substance Addiction -- 2.2.1 What Is Substance Addiction? -- 2.2.2 Dependence Versus Addiction -- 2.2.3 How to Diagnose Substance Addiction? -- 2.3 Non-substance Addiction -- 2.3.1 Pathological Gambling -- 2.3.1.1 What Is Pathological Gambling? -- 2.3.1.2 Recreational Versus Pathological Gambling -- 2.3.1.3 How to Diagnose Pathological Gambling? -- 2.3.2 Food Addiction -- 2.3.2.1 What Is Food Addiction? -- 2.3.2.2 Food Addiction Verse Eating Disorders -- 2.3.2.3 How to Diagnose Food addiction? -- 2.3.3 Internet Addiction -- 2.3.3.1 What Is Internet Addiction? -- 2.3.3.2 How to Diagnose Internet Addiction? -- 2.3.4 Mobile Phone Addiction -- 2.3.4.1 What Is Mobile Phone Addiction? -- 2.3.4.2 How to Diagnose Mobile Phone Addiction? -- 2.4 Conclusion -- References -- Part II: Comparison Between Substance and Non- substance Addictions in Mechanism -- Chapter 3: Similarities and Differences in Neurobiology -- 3.1 Introduction -- 3.2 Similarities and Differences -- 3.2.1 Dopamine -- 3.2.2 Serotonin -- 3.2.3 Opioid -- 3.2.4 Glutamate -- 3.2.5 Norepinephrine/Noradrenaline -- 3.3 Conclusions -- References. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Chapter 4: Similarities and Differences in Genetics -- 4.1 Introduction -- 4.2 Similarities in Genetics -- 4.2.1 DA System -- 4.2.1.1 Dopamine Receptor (DR) Genes -- 4.2.1.2 Dopamine Transporter (DAT) Gene -- 4.2.2 5-HT System -- 4.2.2.1 5-HT Transporter (5-HTT) Gene (5-HTT/SLC18A2) -- 4.2.2.2 5-HT Receptor Gene -- 4.2.3 Other Related Genes -- 4.2.3.1 μ Opioid Receptor (OPRM1) Gene -- 4.2.3.2 Catecholamine-O-Methyltransferase (COMT) Gene -- 4.2.3.3 Monoamine Oxidase A (MAOA) Gene -- 4.3 Differences in Genetics Between Substance Addiction and Non-substance Addiction -- 4.3.1 5-HTT -- 4.3.2 BDNF -- 4.4 Summary and Prospect -- References -- Chapter 5: Similarities and Differences in Neuroimaging -- 5.1 Introduction -- 5.2 Structural Changes -- 5.2.1 Gray Matter Changes -- 5.2.2 White Matter Changes -- 5.3 Functional Changes -- 5.3.1 PET and SPECT -- 5.3.1.1 Glucose Metabolism -- 5.3.1.2 Dopamine -- 5.3.2 Resting-State fMRI -- 5.3.3 Task-State fMRI -- 5.3.3.1 Cue-Induced Brain Activation -- 5.3.3.2 Reward Task -- 5.4 Conclusion -- References -- Chapter 6: Similarities and Differences in Psychology -- 6.1 Introduction -- 6.2 Similarities and Differences -- 6.2.1 Sensation Seeking -- 6.2.2 Inhibitory Control -- 6.2.3 Attentional Bias -- 6.2.4 Intertemporal Choice -- 6.2.5 Environment -- 6.3 Summary and Prospect -- References -- Part III: Comparison Between Substance and Non- substance Addictions in Diagnosis -- Chapter 7: Similarities and Differences in Diagnostic Criterion -- 7.1 Diagnostic Criteria of Addiction -- 7.1.1 Diagnostic Criteria of Substance Addiction -- 7.1.2 Diagnostic Criteria of Non-substance Addiction -- 7.1.2.1 Diagnostic Criteria of Gambling Disorder -- 7.1.2.2 Diagnostic Criteria of Internet Addiction -- 7.1.2.3 Diagnostic Criteria of Food Addiction -- 7.1.2.4 Diagnostic Criteria of Hypersexual Disorder -- 7.1.3 Conclusions. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 7.2 Animal Models Evolved to Resemble the Diagnostic Criteria of Addiction -- 7.2.1 Animal Models Evolved to Resemble the Diagnostic Criteria of Substance Addiction -- 7.2.1.1 Appearance of DSM-IV Criteria in Animal Studies of Substance Addiction -- 7.2.2 Animal Models Evolved to Resemble the Diagnostic Criteria of Gambling Disorder -- 7.2.2.1 Paradigms Built to Study Gambling Proneness in Animal Models -- 7.2.2.2 Proposed Improvements for Animal Models of Gambling Disorder -- 7.2.3 Conclusions -- 7.3 Conclusions -- Appendices (Tables 7.11, 7.12, 7.13, 7.14, 7.15, 7.16, 7.17, 7.18, and 7.19) -- References -- Chapter 8: Similarities and Differences in Diagnostic Scales -- 8.1 Introduction -- 8.2 Development of Substance Addiction Scales -- 8.2.1 Scales of Common Substance Addiction -- 8.2.1.1 Alcohol Addiction Scales -- 8.2.1.2 Nicotine Addiction Scales -- 8.2.2 Scales of Other Substance Addiction -- 8.2.3 Analyses of Substance Addiction Scales -- 8.2.3.1 Comparison Among Substance Scales -- 8.2.3.2 Comparison Between Substance Scales and the Diagnostic Criteria in the DSM-V -- 8.3 Development of Non-substance Addiction Scales -- 8.3.1 Scales of Common Non-substance Addictions -- 8.3.1.1 Pathological Gambling -- 8.3.1.2 Pathological Internet Use -- 8.3.1.3 Internet Gaming Addiction -- 8.3.2 Scales of Other Non-substance Addiction -- 8.3.2.1 Exercise Addiction -- 8.3.2.2 Sex Addiction -- 8.3.2.3 Work Addiction -- 8.3.2.4 Shopping Addiction -- 8.3.3 Analyses of Non-substance Addiction Scales -- 8.3.3.1 Comparison of Non-substance Addiction Scales -- 8.3.3.2 Comparison of Non-substance Addiction Scales and DSM-V -- Comparison of Pathological Gambling Scales, Pathological Internet Use Scales and the Diagnostic Criteria of Pathological Gambling in DSM-V. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Comparison of Internet Gaming Addiction Scales, Pathological Internet Use Scales and the Diagnostic Criteria of Internet Gaming Disorder in DSM-V -- Comparison of Other Non-substance Addiction Scales and the DSM-V -- 8.4 Comparisons of Substance Addiction and Non-substance Addiction Scales -- 8.4.1 Comparisons of Addiction Scales Based on the DSM-V and Other Criteria -- 8.4.2 Applicability of Substance and Non-substance Scales -- 8.4.3 Trends in Substance and Non-substance Addiction Scales -- 8.5 Conclusion -- References -- Chapter 9: Biochemical Diagnosis in Substance and Non-substance Addiction -- 9.1 Substance and Its Metabolites -- 9.2 Biochemical/Biomolecular Responses to Substances and Addictive Behaviours -- 9.2.1 Developed Biomarker for Alcoholism -- 9.2.2 Hypothalamic-Pituitary-Adrenal Axis hormones -- 9.2.3 Neurotrophic Factors -- 9.2.4 Inflammatory Factors -- 9.2.5 Indicators of Vascular Injury -- 9.2.6 Lipids and Adipocyte-Derived Hormones -- 9.2.7 Other Proteins -- 9.3 Epigenetic and Genetic Biomarkers -- 9.3.1 Methylation of DNAs -- 9.3.2 Serum microRNAs -- 9.3.3 Genetic Markers -- References -- Chapter 10: Development of New Diagnostic Techniques - Machine Learning -- 10.1 Previous Diagnoses of Addiction and Their Shortcomings -- 10.2 A Brief Introduction of Machine Learning -- 10.3 The Steps of Using ML for Diagnose -- 10.3.1 Pre-processing -- 10.3.2 Model Training -- 10.3.3 Cross-Validation -- 10.4 Previous Studies of Addiction-Related ML -- 10.4.1 Separating Addicts and Non-addicts -- 10.4.2 Separate Different Subtypes of Addiction -- 10.4.3 Evaluating the Effects of Treatment -- 10.4.4 Employing Multiple Measures to Classify Subjects -- 10.5 Shortcomings -- 10.6 Conclusion -- References -- Part IV: Comparison Between Substance and Non- substance Addictions in Treatment -- Chapter 11: Drug Therapy -- 11.1 Introduction. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 11.2 Basic Principles of Addiction Therapy -- 11.3 Core Content of Addiction Therapy -- 11.4 Trends in Addiction Therapy -- 11.5 Drug Therapy of Substance Addiction -- 11.5.1 Drugs for Alcohol Addiction Rehabilitation -- 11.5.1.1 Alcohol Sensitizer -- 11.5.1.2 Opioid Receptor Antagonist -- 11.5.1.3 Acamprosate -- 11.5.1.4 Anticonvulsive Drugs -- 11.5.1.5 Baclofen -- 11.5.2 Drug Therapy of Benzodiazepine Sedative and Hypnotic Drug Addiction -- 11.5.3 Drug Therapy of Opioid Drug Addiction -- 11.5.3.1 Drug Therapy of Opioid Drug Addiction at Acute Withdrawal Stage -- Opioid Receptor Agonist and Some Receptor Agonist -- Non-opioid Drug Therapy -- Ultra-rapid Opioid Detoxification Under General Anesthesia -- 11.5.3.2 Long-Term Therapy of Opioid Drug Addiction -- Protracted Abstinence Syndrome -- Naltrexone Maintenance Therapy -- Methadone Maintenance Therapy -- Buprenorphine Maintenance Therapy -- 11.5.3.3 Therapy by Chinese Herbs -- 11.5.4 Drug Therapy of Cocaine, Amphetamine and Other Stimulant Addiction -- 11.5.4.1 Pharmacological Mechanisms of Drugs Treating Cocaine Addiction -- 11.5.4.2 Selection on Drug Therapy -- (Antidepressants) -- Dopamine Agonist (Anti-Parkinson's Agent) -- Stimulants -- Antipsychotics -- Anti-seizure Drugs -- 11.5.4.3 Amphetamine Addiction -- 11.5.5 Drug Therapy of Nicotine Addiction -- 11.5.5.1 Nicotine Replacement Therapy (NRT) -- 11.5.5.2 Non-nicotine Products Include -- Bupropion -- Varenicline -- Nortriptyline -- Clonidine -- 11.5.6 Pharmacological Interventions for Other Drug Addiction and Multi-drug Mixed Addiction -- 11.5.6.1 Cannabis -- 11.5.6.2 (Phencyclidine,PCP) -- 11.5.6.3 Hallucinogens -- 11.5.6.4 Ketamine -- 11.5.6.5 Prescribed Drug Addiction -- 11.6 Drug Therapy of Non-substance Addiction -- 11.6.1 Drug Therapy of Gambling Addiction -- 11.6.2 Drug Therapy of Internet Addiction. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 11.6.3 Drug Therapy of Sexual Addiction and Sexual Preference Disorders. |
| 588 ## - SOURCE OF DESCRIPTION NOTE | |
| Source of description note | Description based on publisher supplied metadata and other sources. |
| 590 ## - LOCAL NOTE (RLIN) | |
| Local note | Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Substance abuse--Treatment. |
| 655 #4 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Shi, Jie. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tao, Ran. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Print version: |
| Main entry heading | Zhang, Xiaochu |
| Title | Substance and Non-Substance Addiction |
| Place, publisher, and date of publication | Singapore : Springer Singapore Pte. Limited,c2017 |
| International Standard Book Number | 9789811055614 |
| 797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN) | |
| Corporate name or jurisdiction name as entry element | ProQuest (Firm) |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
| Uniform title | Advances in Experimental Medicine and Biology Series |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=5122222">https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=5122222</a> |
| Public note | Click to View |
No items available.